After Stroke, Intensive Antiplatelet Therapy Has Benefits, Drawbacks
Intensive antiplatelet therapy appears to reduce risk of recurrence immediately after stroke, but may pose risks further out.
Intracerebral Hemorrhage
Intracerebral Hemorrhage Outcomes Improved With Anticoagulants
Resumption of oral anticoagulants after intracerebral hemorrhage was found to improve outcomes at 1 year.
In Intracerebral Hemorrhage, Intensive BP Lowering Has Little Impact on Outcomes
The investigators reported no difference in 3-month mortality rates across all 5 studies included in the meta-analysis.
Oral Anticoagulation After ICH: Risks and Outcomes
Restarting anticoagulation after both nonlobar and lobar ICH was associated with decreased mortality.
Medical Complications After ICH: Changes in the Last Decade
As more patients survive ICH, emphasis is slowly shifting from survival to improving ICH-related morbidity and optimization of functional recovery.
Cilostazol Helps Prevent Secondary Stroke But Not Without Risk
Optimal antiplatelet treatment has yet to be determined for stroke survivors with prior intracerebral hemorrhage.
Dementia, Depression Common After Intracerebral Hemorrhage
Among ICH survivors, 63% developed both depression and dementia during a 5-year follow-up study.
Pushing the Limits of Endovascular Therapy for Acute Ischemic Stroke
Recent research found benefits in outcome outweighed any increase in hemorrhagic complications in patients with large infarcts.
Antiplatelet Use Linked to Hematoma Growth, Outcomes in Intracerebral Hemorrhage
Notably, the location of ICH influenced the association with hematoma volume and growth in patients with prior antiplatelet use.
Cerebral Microbleeds and Risk of Intracerebral Hemorrhage After Stroke
Cerebral microbleeds increase the risk for symptomatic ICH after thrombolysis for acute ischemic stroke.
